ICD-10 Coding for Lung Cancer with Metastases(C34.0, C34.90, C34.90B)
Comprehensive guide on ICD-10 coding for lung cancer with metastases, including primary and secondary codes, documentation requirements, and coding pitfalls.
Complete code families applicable to Lung Cancer with Metastases
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung | Use when the specific site or laterality of the lung cancer is not documented. |
|
| C79.31 | Secondary malignant neoplasm of brain | Use when brain metastases are confirmed and the primary site is lung. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutLung Cancer with Metastases
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Lung Cancer with Metastases.
Using unspecified codes without supporting documentation
Impact
Clinical: Leads to inadequate treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims and reduced reimbursement.
Mitigation
Ensure detailed documentation of cancer sites, Use specific codes whenever possible
Using C78.00 for primary lung cancer
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate data on cancer prevalence and treatment.
Mitigation
Confirm the origin of the cancer and use C34.xx for primary lung cancers.
Unspecified coding
Impact
High risk of audits due to use of unspecified codes without justification.
Mitigation
Use specific codes and ensure thorough documentation.